Skip to main content
Clinical Trials/CTRI/2024/05/067003
CTRI/2024/05/067003
Not yet recruiting
Phase 2/3

A Randomized clinical controlled trial on speech fluency disorders in children with combination of Anutail Nasya and Vagshudhikar Churna

Dr shubhangi thakur1 site in 1 country70 target enrollmentStarted: May 23, 2024Last updated:

Overview

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Dr shubhangi thakur
Enrollment
70
Locations
1
Primary Endpoint
evaluation of dysfluencies during reading and conversation by using 100 word sample method

Overview

Brief Summary

This study is randomized clinical controlled trial comparing the saftey and efficacy of  combination of vagshudhikar churna doses for patient according to age for three months with  Anu tail Nasaya 3cycles of 21 days and another group will be with only speech therapy in age 2 to 12 years of age children the primary outcome measures will be evaluation of dysfluencies during reading at 6 weeks the secondary outcome will be overall effectiveness and better approach towards the treatement of fluency disorders at 12 weeks

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
2.00 Year(s) to 12.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • children of the age group of 2 -12 Years Speech related problems in consequence with delayed developmental Milestones.

Exclusion Criteria

  • Suffering from sensory aphasia or dysphasia Children suffering from cleft palate& Cleft lip or the conditions where the surgical intervention is required Speech disorders secondary to disorders like cerebral palsy are excluded Speech disorders which are complicated with other systemic disorders Children suffering from Dysphonia & Dysarthria.

Outcomes

Primary Outcomes

evaluation of dysfluencies during reading and conversation by using 100 word sample method

Time Frame: 6 weeks

Secondary Outcomes

  • efectiveness of treatement and better approach towards modification of treatement on fluency disorders(12 weeks)

Investigators

Sponsor
Dr shubhangi thakur
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Shubhangi thakur

Government Ayurved college Osmanabad

Study Sites (1)

Loading locations...

Similar Trials